UTHR vs WSBCO
United Therapeutics Corporation (UTHR) versus WesBanco, Inc. (WSBCO) — a side-by-side from cached financials, not a winner call.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
WesBanco, Inc. (WSBCO) is a banks - regional company listed on NASDAQ.
Latest reported UTHR revenue for 2024-12-31 was $2.88B. Net income was $1.20B. Revenue was up 23.6% from 2023-12-31 to 2024-12-31. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
WSBCO does not have a complete income-statement cache yet.
UTHR currently screens at market cap $23.41B and trailing P/E 20.4. WSBCO currently screens at market cap $0.
Not investment advice. Open the UTHR and WSBCO stock pages for the full models.
Not investment advice.